Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NexGen Arrays
AddedFeb 18, 2024
UpdatedJun 18, 2026
NexGen Arrays

NexGen Arrays

NexGen Arrays: Revolutionizing healthcare with our next-gen molecular diagnostic platform for robust, affordable pathogen detection.

HQ
Boston, MA, US
Founded
2013
Overview
Compare
Fundraising
Employees

NexGen Arrays is dedicated to revolutionizing healthcare with its next-generation molecular diagnostic platform, focusing on robust and affordable pathogen detection. The company's SP-IRIS sensor has demonstrated the ability to perform multiplexed single virus detection in unprocessed whole blood at clinically relevant levels, with forward compatibility for single molecule detection of both proteins and nucleic acids.

NexGen Arrays has made significant strides in making multiple pathogen detection simple and sensitive for clinicians. Their innovative technology aims to enhance diagnostic accuracy and accessibility, potentially transforming the landscape of molecular diagnostics.

NexGen Arrays - Similar Companies

SenGenix logo

SenGenix

sengenix.com

Torus Biosystems logo

Torus Biosystems

PathogenDx logo

PathogenDx

pathogendx.com

Guanine logo

Guanine

guanineinc.com

OmniVis logo

OmniVis

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

GeneCapture logo

GeneCapture

genecapture.com

NuProbe logo

NuProbe

nuprobe.com

NAT Diagnostics logo

NAT Diagnostics

DxNA logo

DxNA

Karius logo

Karius

kariusdx.com

Nanopath logo

Nanopath

nanopathdx.com

Accelevir Diagnostics logo

Accelevir Diagnostics

Genendeavor logo

Genendeavor

genendeavor.com

MultiplexDX logo

MultiplexDX

multiplexdx.com

NexGen Arrays - Quick Facts

Who are NexGen Arrays' competitors?

Companies similar to NexGen Arrays include SenGenix, Torus Biosystems, PathogenDx and Guanine.

When was NexGen Arrays founded?

NexGen Arrays was founded in 2013.

Where is NexGen Arrays' headquarters located?

NexGen Arrays' headquarters is located in Boston, MA, US.

When was NexGen Arrays' last funding round?

NexGen Arrays' most recent funding round was for $150k (USD) in December 2014.

How much has NexGen Arrays raised to-date?

As of Dec 1, 2014, NexGen Arrays has raised a total of $150k (USD).

How many employees does NexGen Arrays have?

NexGen Arrays has 5 employees as of Feb 4, 2024.

NexGen Arrays - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
  • Biotech
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostic Tests
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software